1,178
Views
1
CrossRef citations to date
0
Altmetric
Oncology

Health-related quality-of-life in treatment-naive CLL/SLL patients treated with zanubrutinib versus bendamustine plus rituximab

, , , , , ORCID Icon, , , , & show all
Pages 1505-1511 | Received 26 Jul 2023, Accepted 20 Sep 2023, Published online: 12 Oct 2023

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.